Old National Bancorp Regeneron Pharmaceuticals, Inc. Transaction History

Old National Bancorp

$4.24 Billion
Q2 2024

A detailed history of Old National Bancorp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Old National Bancorp holds 278 shares of REGN stock, worth $294,919. This represents 0.01% of its overall portfolio holdings.

Number of Shares

278

Previous 274 1.46%

Holding current value

$294,919

Previous $263,000 11.03%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$883.2 - $1071.19 $3,532 - $4,284	4 Added 1.46%	278 $292,000
Q1 2024 Apr 15, 2024	BUY	$902.69 - $993.35 $247,337 - $272,177	274 New	274 $263,000
Q3 2020 Oct 29, 2020	SELL	$544.75 - $658.21 $220,079 - $265,916	-404 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$493.32 - $643.92 $125,796 - $164,199	-255 Reduced 38.69%	404 $252,000
Q1 2020 Apr 24, 2020	SELL	$336.18 - $494.43 $228,266 - $335,717	-679 Reduced 50.75%	659 $322,000

Q4 2019 Jan 16, 2020	SELL	$274.13 - $376.51 $2.83 Million - $3.88 Million	-10,315 Reduced 88.52%	1,338 $503,000
Q3 2019 Oct 22, 2019	SELL	$273.46 - $318.39 $18,595 - $21,650	-68 Reduced 0.58%	11,653 $3.23 Million
Q2 2019 Jul 15, 2019	BUY	$299.6 - $414.82 $154,593 - $214,047	516 Added 4.61%	11,721 $3.67 Million
Q1 2019 Apr 30, 2019	BUY	$372.08 - $439.57 $647,419 - $764,851	1,740 Added 18.38%	11,205 $4.6 Million
Q4 2018 Jan 31, 2019	BUY	$335.82 - $403.04 $842,908 - $1.01 Million	2,510 Added 36.09%	9,465 $3.54 Million
Q3 2018 Oct 26, 2018	BUY	$351.14 - $408.51 $2.44 Million - $2.84 Million	6,955 New	6,955 $2.81 Million

Others Institutions Holding REGN

# of Institutions

1,440

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $114B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

News

Stay updated on Old National Bancorp with notifications on news.

Account

Old National Bancorp Regeneron Pharmaceuticals, Inc. Transaction History